Disclosed are compounds of formula (I) below or pharmaceutically acceptable salts thereof: in which each of variables R1-R6, L, m, and n is defined herein. Also disclosed are a method for treating an opioid receptor-associated condit
-
Paragraph 0060-0061; 0144-0145
(2019/03/30)
HETEROCYCLIC COMPOUNDS AND USE THEREOF
Disclosed are compounds of formula (I) below or pharmaceutically acceptable salts thereof:in which each of variables R 1 -R 6 , L, m, and n is defined herein. Also disclosed are a method for treating an opioid receptor-associated condition with a compound
-
Paragraph 0061; 0105
(2019/07/23)
Method for preparing (R)-praziquantel
The invention relates to a new method for preparing (R)-praziquantel. In the invention, by taking advantage of the high stereo selectivity, site selectivity and region selectivity of an enzyme, an intermediate of a pure optical and chiral (R)-praziquantel
-
Page/Page column 21
(2015/07/07)
More Articles about upstream products of 55375-96-7